Senior living leaders to discuss pressing topics Sept. 11 at free virtual event
By
Lois A. Bowers
Sep 06, 2024
Get insights into how other senior living providers are innovating and addressing challenges when a panel of industry leaders discusses important issues facing assisted living providers — as well as...
Outdoor nighttime light exposure linked to prevalence of Alzheimer’s disease
By
Haymarket Media
Sep 06, 2024
Nighttime light exposure was more strongly linked to AD prevalence than any other disease factor among those younger than 65 years.
Toward a common definition of assisted living
By
Sheryl Zimmerman, PhD
Sep 03, 2024
As part of its ongoing national collaborative to further the well-being of those who live and work in assisted living, the Center for Excellence in Assisted Living has released a definition of assisted...
Protecting senior living residents from respiratory viruses means educating the community around them
By
Kimberly Bonvissuto
Sep 11, 2024
When it comes to increasing vaccination rates against respiratory viruses, it’s not only important to educate senior living residents about the value of vaccines; it’s also important to educate their...
Is Eli Lilly using ‘granfluencers’ to raise awareness of its Alzheimer’s med?
By
Marc Iskowitz
Sep 04, 2024
Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer’s drug marketing scene.
Cholinesterase inhibitors beneficial for dementia with Lewy bodies
By
Haymarket Media
Aug 28, 2024
The use of cholinesterase inhibitors significantly slowed cognitive decline at follow-ups compared with memantine and nonuse.
No spike in schizophrenia, other diagnoses among people with dementia after feds crack down on antipsychotic...
By
Kimberly Marselas
Aug 28, 2024
Federal policies designed to reduce use of antipsychotic medications in nursing homes did not lead to clinically significantly higher rates of schizophrenia diagnoses among people living with dementia,...
Risk for dementia similar with SGLT2 inhibitors, dulaglutide in T2DM
Aug 26, 2024
The estimated risk difference varied from −2.45 to 0.63 percentage points with SGLT2 versus dulaglutide among older adults.
Significant assisted living regulation changes bring challenges for providers, more options for residents
By
Kimberly Bonvissuto
Aug 30, 2024
Significant new regulations for assisted living that just began rolling out this summer have created significant challenges for providers in Kentucky, but the end result will be more options for residents...
Multiple sclerosis linked to lower risk for Alzheimer’s disease pathology
By
Haymarket Media
Aug 30, 2024
A lower rate of amyloid-β plasma biomarker positivity was seen in multiple sclerosis patients compared with non-MS controls.